• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

CATEGORIES

  • 2

PRICE

1
1
2
2

PUBLISHED

0
0
0
2

PRODUCT TYPE

2

Search "Shanghai Dongbao Biopharmaceutical Co., Ltd.-Therapeutic Competitors Report" returned 2 results.

PRODUCT TITLE
Competitor Analysis: Insulin Competitor Analysis: Insulin - Product Thumbnail Image

Competitor Analysis: Insulin

The Competitive Intelligence Report Insulin as of January 2011 provides a competitor analysis in the development pipeline of novel insulin-based products for treatment of type 1 and 2 diabetes Purchase...

January 2011
FROM
Competitor Analysis: Diabetes Drug Pipeline Competitor Analysis: Diabetes Drug Pipeline - Product Thumbnail Image

Competitor Analysis: Diabetes Drug Pipeline

This Competitive Intelligence report on the Diabetes Drug Pipeline, as of November 2008 provides a competitor analysis in the development pipeline of novel antidiabetic treatment modalities for type...

November 2008
FROM
Loading Indicator

Our Clients

Amneal Pharmaceuticals LLC. Amgen Inc. LEO Laboratories Ltd. Pfizer, Inc. Roche Diagnostics Ltd. Merck & Co., Inc. Sanofi S.A.